Dr. Gabrielle M. Adams, MD

Dr. Adams practices at Southwest Endoscopy - Albuquerque in Albuquerque, New Mexico.

Dr. Adams' NPI, 1477552958, was assigned on July 18, 2005. Dr. Adams graduated from UCSF School of Medicine in 1990. Dr. Adams holds New Mexico license 97-176.

Dr. Adams' primary practice is Southwest Endoscopy - Albuquerque, at 7788 Jefferson NE, Albuquerque, NM 87109. The practice phone is (505) 999-1600.

Dr. Adams' primary practice is Southwest Endoscopy - Albuquerque in Albuquerque, New Mexico. Dr. Adams is also affiliated with Presbyterian Hospital. The medical group on file is Southwest Gastroenterology Associates. Dmand AI also links Dr. Adams to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adams practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Adams' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Adams is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Adams' licenses on file in 2 states: New Mexico and Texas.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Adams treats.

CMS data shows 670 Medicare services from Dr. Adams across 8 procedure codes in 2024, for 481 Medicare patients. Medicare paid $68,432 for them.

CMS counts 481 Medicare patients who saw Dr. Adams in 2024. The largest group is 65 to 74, with 262 patients. 69% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Adams' median patient age at 70, with 76% women.

In 2024, Dr. Adams wrote 913 Medicare Part D claims for 260 patients. 91% of them were for generic drugs. CMS names the drug for 762 of them, across 15 drugs with 11 or more claims each, at $561,101 in total drug cost. In 2023, CMS named 583 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Adams for performance year 2024, reported individually. Dr. Adams accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Adams as offering telehealth. CMS counts 111 procedures of colonoscopy by Dr. Adams, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Adams. Dr. Adams' most frequent co-authors are Lara Barkoff, MD, Jennifer Nicole Caudle, DO and Jianfeng Cheng, MD, PhD.

CMS Open Payments shows 94 general payments to Dr. Adams from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $949.

Dmand AI lists 1 award for Dr. Adams, most recently CMS Stage 1 2012 in 2012.

Dr. Adams graduated from UCSF School of Medicine in 1990.

Dr. Adams is in network with 15 carriers, including Elevance, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.